116 related articles for article (PubMed ID: 22549023)
61. A Radioactive-free Kinase Inhibitor Discovery Assay Against the
Efstathiou A; Smirlis D
Bio Protoc; 2020 Jan; 10(2):e3493. PubMed ID: 33654724
[TBL] [Abstract][Full Text] [Related]
62. Subverting lysosomal function in
Alsford S
Microb Cell; 2015 Aug; 2(8):259-261. PubMed ID: 27441200
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of cathepsin E by diazoacetyl-norleucine methyl ester.
Keilová H; Lapresle C
FEBS Lett; 1970 Sep; 9(6):348-350. PubMed ID: 11947712
[No Abstract] [Full Text] [Related]
64. Inhibition of cathepsin D by diazoacetylnorleucine methyl ester.
Keilová H
FEBS Lett; 1970 Feb; 6(4):312-314. PubMed ID: 11947403
[No Abstract] [Full Text] [Related]
65. Drug Discovery Efforts to Identify Novel Treatments for Neglected Tropical Diseases - Cysteine Protease Inhibitors.
Giroud M; Kuhn B; Haap W
Curr Med Chem; 2024; 31(16):2170-2194. PubMed ID: 37916489
[TBL] [Abstract][Full Text] [Related]
66. Cysteine Proteases as Validated Targets for the Treatment of Neglected and Poverty-Related Parasitic Diseases.
Ettari R
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373243
[TBL] [Abstract][Full Text] [Related]
67. Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis.
Saha A; Pushpa ; Moitra S; Basak D; Brahma S; Mondal D; Molla SH; Samadder A; Nandi S
Curr Med Chem; 2024; 31(16):2135-2169. PubMed ID: 37340748
[TBL] [Abstract][Full Text] [Related]
68. Targeted protein degradation might present a novel therapeutic approach in the fight against African trypanosomiasis.
Danazumi AU; Ishmam IT; Idris S; Izert MA; Balogun EO; Górna MW
Eur J Pharm Sci; 2023 Jul; 186():106451. PubMed ID: 37088149
[TBL] [Abstract][Full Text] [Related]
69.
Costa TFR; Goundry A; Morrot A; Grab DJ; Mottram JC; Lima APCA
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614101
[TBL] [Abstract][Full Text] [Related]
70. First Molecular Identification of Trypanosomes and Absence of
Carrillo-Bilbao G; Navarro JC; Martin-Solano S; Chávez-Larrea MA; Cholota-Iza C; Saegerman C
Pathogens; 2022 Dec; 11(12):. PubMed ID: 36558823
[TBL] [Abstract][Full Text] [Related]
71. Two Tags in One Probe: Combining Fluorescence- and Biotin-based Detection of the Trypanosomal Cysteine Protease Rhodesain.
Lemke C; Jílková A; Ferber D; Braune A; On A; Johe P; Zíková A; Schirmeister T; Mareš M; Horn M; Gütschow M
Chemistry; 2022 Nov; 28(62):e202201636. PubMed ID: 35852812
[TBL] [Abstract][Full Text] [Related]
72. Structure, interdomain dynamics, and pH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from African trypanosomes.
Johé P; Jaenicke E; Neuweiler H; Schirmeister T; Kersten C; Hellmich UA
J Biol Chem; 2021; 296():100565. PubMed ID: 33745969
[TBL] [Abstract][Full Text] [Related]
73. Transcriptome of Sphaerospora molnari (Cnidaria, Myxosporea) blood stages provides proteolytic arsenal as potential therapeutic targets against sphaerosporosis in common carp.
Hartigan A; Kosakyan A; Pecková H; Eszterbauer E; Holzer AS
BMC Genomics; 2020 Jun; 21(1):404. PubMed ID: 32546190
[TBL] [Abstract][Full Text] [Related]
74. Drug Synergism: Studies of Combination of RK-52 and Curcumin against Rhodesain of
Ettari R; Previti S; Di Chio C; Maiorana S; Allegra A; Schirmeister T; Zappalà M
ACS Med Chem Lett; 2020 May; 11(5):806-810. PubMed ID: 32435388
[TBL] [Abstract][Full Text] [Related]
75. Peptidomimetic Vinyl Heterocyclic Inhibitors of Cruzain Effect Antitrypanosomal Activity.
Chenna BC; Li L; Mellott DM; Zhai X; Siqueira-Neto JL; Calvet Alvarez C; Bernatchez JA; Desormeaux E; Alvarez Hernandez E; Gomez J; McKerrow JH; Cruz-Reyes J; Meek TD
J Med Chem; 2020 Mar; 63(6):3298-3316. PubMed ID: 32125159
[TBL] [Abstract][Full Text] [Related]
76. On the Reversible and Irreversible Inhibition of Rhodesain by Curcumin.
Steverding D
Molecules; 2019 Dec; 25(1):. PubMed ID: 31905815
[TBL] [Abstract][Full Text] [Related]
77. Comparative proteomic analysis of mitochondria isolated from Euglena gracilis under aerobic and hypoxic conditions.
Tamaki S; Nishino K; Ogawa T; Maruta T; Sawa Y; Arakawa K; Ishikawa T
PLoS One; 2019; 14(12):e0227226. PubMed ID: 31891638
[TBL] [Abstract][Full Text] [Related]
78. Secreted cathepsin L-like peptidases are involved in the degradation of trapped antibodies on the surface of Echinostoma caproni.
Cortés A; Mikeš L; Muñoz-Antolí C; Álvarez-Izquierdo M; Esteban JG; Horák P; Toledo R
Parasitol Res; 2019 Dec; 118(12):3377-3386. PubMed ID: 31720841
[TBL] [Abstract][Full Text] [Related]
79. Benzimidazole inhibitors of the major cysteine protease of
Pereira GA; Santos LH; Wang SC; Martins LC; Villela FS; Liao W; Dessoy MA; Dias LC; Andricopulo AD; Costa MA; Nagem RA; Caffrey CR; Liedl KR; Caffarena ER; Ferreira RS
Future Med Chem; 2019 Jul; 11(13):1537-1551. PubMed ID: 31469332
[No Abstract] [Full Text] [Related]
80. Discovery and characterization of trypanocidal cysteine protease inhibitors from the 'malaria box'.
Pereira GAN; da Silva EB; Braga SFP; Leite PG; Martins LC; Vieira RP; Soh WT; Villela FS; Costa FMR; Ray D; de Andrade SF; Brandstetter H; Oliveira RB; Caffrey CR; Machado FS; Ferreira RS
Eur J Med Chem; 2019 Oct; 179():765-778. PubMed ID: 31284086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
